Researchers have identified 102 genes associated with risk for autism, helping to differentiate the genes associated with ASD from those associated with intellectual disability and developmental delay, conditions which often overlap.

A team has analyzed the role of immune cells in the expansion of glioblastoma, a type of aggressive brain tumor.

Information about an artwork has no effect on the aesthetic experience of museum visitors, whilst characteristics of the artwork itself have a much stronger impact on observers, suggests new findings from the University of Basel.

Historically, efforts to target the substance P (SP) neurokinin 1 receptor (NK1R), for the treatment of pain have failed. These studies had one critical flaw, whilst they were targeting the right receptor, they were focusing on the wrong location.

In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.

You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.

As a neuroscientist researching how food and drink affect brain function, let me explain how drinking alcohol can trigger hangxiety the next day.

Working fewer hours isn’t only associated with improved health and psychological benefits; it can also help us to become more productive.

Fred Barrett is an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University in Baltimore. In this interview, we discuss his work with the active component of magic mushrooms, psilocybin. Fred explains how this compound affects the brain, its potential to combat visceral pain, and its links to so-called mystical experiences.